Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Cancer of the Pancreas Screening-5 (CAPS5) Study
NCT02000089Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Jan 2014
- Primary completion
- Dec 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of secretin in pancreatic cancer (PC), sponsored by Johns Hopkins University. Started Jan 2014; status: recruiting.
02
Drugs
secretin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02000089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02000089.